118 / 119
117
Diretrizes AMB
etanercept for moderate-to-severe psoriasis. N Engl J Med. 2010 Jan
14;362(2):118-28. PubMed PMID: 20071701.
39. Strober BE, Crowley JJ, Yamauchi PS, Olds M, Williams DA. Efficacy and
safety results from a phase III, randomized controlled trial comparing
the safety and efficacy of briakinumab with etanercept and placebo in
patients with moderate to severe chronic plaque psoriasis. Br J Dermatol.
2011 Sep;165(3):661-8. PubMed PMID: 21574984.